STAAR Surgical (NASDAQ:STAA) rose 7.2% amid some takeover speculation.
The maker of implantable lenses is said to have been approached by larger rival Alcon (ALC), according to a StreetInsider report on Wednesday, which cited an unidentified source. It's not clear if the approach will lead to a deal.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,